Abstract
Runt domain transcription factor 3 (RUNX3) suppresses many different cancer types and is disabled by mutations, epigenetic repression, or cytoplasmic mislocalization. In this study, we investigated whether oxidative stress is associated with RUNX3 accumulation from the nucleus to the cytoplasm in terms of histone modification. Oxidative stress elevated histone deacetylase (HDAC) level and lowered that of histone acetyltransferase. In addition, oxidative stress decreased the expression of mixed lineage leukemia (MLL), a histone methyltransferase, but increased the expression of euchromatic histone-lysine N-methyltransferase 2 (EHMT2/G9a), which is also a histone methyltransferase. Moreover, oxidative stress-induced RUNX3 phosphorylation, Src activation, and Jun activation domain-binding protein 1 (JAB1) expression were inhibited by knockdown of HDAC and G9a, restoring the nuclear localization of RUNX3 under oxidative stress. Cytoplasmic RUNX3 localization was followed by oxidative stress-induced histone modification, activated Src along with RUNX3 phosphorylation, and induction of JAB1, resulting in RUNX3 inactivation.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Runt-related transcription factor 3 (RUNX3), a member of the Runt domain family and a nuclear transcriptional regulator, play important roles in a variety of biological processes, including development, cell proliferation, differentiation, and DNA repair [1, 2]. RUNX3 containing an evolutionarily conserved Runt DNA-binding domain and a C-terminal trans-activating domain functions primarily as a tumor suppressor [3]. RUNX3 is commonly inactive in different types of solid tumors due to epigenetic silencing, mutation, or mislocalization from the nucleus to the cytoplasm [4, 5]. RUNX3 mislocalization from the nucleus to the cytoplasm occurs in various advanced carcinomas, including non-small cell lung cancer, and inactivates tumor suppression, suggesting that nuclear RUNX3 plays a key role in cancer suppression [6,7,8,9].
Jun activation domain-binding protein 1 (JAB1), which is part of the COP9 signalosome (CSN), facilitates nuclear chromosomal region maintenance 1 (CRM1) export and proteasome-mediated RUNX3 degradation [10, 11]. In addition, the Src/Stat3 signaling pathway plays a crucial role in controlling JAB1 transcription in breast cancer cells, and treatment with Stat3 and Src-targeting siRNAs noticeably reduces JAB1 promoter function and expression [12].
Src-mediated RUNX3 phosphorylation induces RUNX3 mislocalization in various cancers, including colon cancer [13, 14]. In Helicobacter pylori, Src-mediated RUNX3 phosphorylation induces cytoplasmic RUNX3 localization [15]. Several epidemiological studies have demonstrated the occurrence of increased levels of reactive oxygen species (ROS) and oxidative stress markers in the blood of patients with colorectal cancer [16, 17]. In addition, the induction of cytoplasmic RUNX3 retention under hypoxic culture condition in gastric cancer cells occurs via the upregulation of histone deacetylase (HDAC) and histone methyltransferase (HMT), euchromatic histone-lysine N-methyltransferase 2 (EHMT2/G9a) [18]. In a previous study, we demonstrated that oxidative stress-inactivated RUNX3 participates in abnormal cell proliferation via Akt/β-catenin/cyclin D cascade activation in human colon cancer cells [19]. Furthermore, we showed that oxidative stress suppressed RUNX3 expression and promoted translocation to the cytoplasm in colon cancer cells by increasing HDAC level [13, 20]. Oxidative stress is known to play a role in critical changes in nuclear transport, leading to protein mislocalization, which in turn contributes to cancer pathogenesis [21,22,23]. However, the correlation between RUNX3, HDAC, HMT, and nuclear exporter under oxidative stress remains unknown.
Therefore, in this study, we investigated the correlation between RUNX3, HDAC, HMT, and nuclear exporter to determine the cytoplasmic distribution of RUNX3 in colon cancer cells under oxidative stress.
Materials and Methods
Cell Viability Assay
SNU-407, a human colon cancer cell line (Korea Cell Line Bank, Seoul, Republic of Korea), was cultured with various concentrations of H2O2 for 24 h. After the addition of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), the absorbance at 540 nm was measured using a scanning multi-well spectrophotometer.
Intracellular ROS Detection
Cells were treated with 25 µM of 2′,7′-dichlorodihydrofluorescein diacetate (H2DCFDA; Molecular Probes, Eugene, OR, USA), a cell-permeant ROS probe, and the fluorescence was detected using a flow cytometer (Becton Dickinson, Mountain View, CA, USA).
Immunofluorescence Assay
Fixed cells were incubated with an antibody against RUNX3, and followed by treatment with an FITC-conjugated secondary antibody (Santa Cruz Biotechnology, Dallas, TX, USA). The stained cells were observed using a confocal microscope equipped with LSM 510 software.
Western Blot Analysis
Cell lysate was electrophoresed, transferred, and incubated with relevant primary antibodies, phospho-RUNX3, RUNX3, TATA-binding protein (TBP), actin (Abcam, Cambridge, MA, USA); phospho-Src, Src, histone acetyltransferase 1 (HAT1), G9a (Cell Signaling Technology, Danvers, MA, USA); JAB1, CRM1, HDAC1, and mixed lineage leukemia (MLL) (Santa Cruz Biotechnology). An immunoglobulin G conjugated with horseradish peroxidase (Pierce, Rockford, IL, USA) was used as secondary antibody. Protein bands were identified using an improved chemiluminescence western blot detection kit (Amersham, Little Chalfont, Buckinghamshire, UK).
Transient Transfection of Small Interfering RNAs (siRNAs)
Cells were transfected with either control siRNA or siRNAs that specifically targeted Src, JAB1, HDAC1, or G9a (referred to as siSrc, siJAB1, siHDAC1, and siG9a, respectively) (Santa Cruz Biotechnology). Transfection was performed using Lipofectamine RNAiMax reagent (Invitrogen, Carlsbad, CA, USA).
Immunoprecipitation Assay
Cell lysates were incubated with antibodies targeting RUNX3, JAB1, CRM1, IgG, and immune complexes were prepared using protein A/G PLUS beads (Santa Cruz Biotechnology). Specific antibodies were used to identify precipitates by western blot analysis.
Proximity Ligation Assay (PLA)
Cells were permeabilized by using the mouse/rabbit red starter Duolink kit according to the manufacturer’s instructions (Sigma-Aldrich, Burlington, MA, USA). The cells were then incubated with primary antibodies, JAB1 (1:100), CRM1 (1:100), and RUNX3 (1:100). The cells were then treated with PLA probes and visualized using a confocal microscope and the LSM 510 program.
Statistical Analysis
All data are presented as mean ± standard error, and the results were subjected to analysis of variance using Tukey’s test. Statistical significance was set at p < 0.05.
Results
Oxidative Stress Induces RUNX3 Mislocalization Via Histone Modification-Related Proteins
To find the optimal concentration of H2O2 treatment to study oxidative stress-induced RUNX3 mislocalization, we tested cell viability at various concentrations of the oxidative stressor H2O2. Cytotoxicity was not observed for concentrations of up to 100 μM H2O2 (Fig. 1A). Therefore, 100 μM H2O2 was considered the optimum concentration to induce RUNX3 mislocalization due to oxidative stress. 100 μM H2O2 increased the ROS levels, but a ROS scavenger, N-acetyl-l-cysteine (NAC), led to a reduction (Fig. 1B). Notably, H2O2 increased RUNX3 mislocalization from the nucleus to the cytoplasm; whereas NAC attenuated this effect (Fig. 1C).
It has been reported that oxidative stress induces the cytoplasmic localization of RUNX3 through HDAC1 [13, 18]. Therefore, to investigate whether histone modifications are involved in oxidative stress-induced RUNX3 mislocalization, the expression of histone modification-related proteins was evaluated. H2O2 treatment increased nuclear HDAC1 protein level in a time-dependent manner up to 12 h and decreased from 24 h, but still increased nuclear HDAC1 protein level to a level greater than that at 0 h (Fig. 1D). Furthermore, H2O2 treatment decreased nuclear histone acetyltransferase 1 (HAT1) protein level in a time-dependent manner (Fig. 1D) and increased G9a expression in the nucleus, but decreased the expression of MLL in a time-dependent manner (Fig. 1D). In addition, RUNX3 expression was opposite that of HDAC1 and G9a, in a time-dependent manner (Fig. 1D). Treatment with NAC inhibited the increased expression of HDAC1 and G9a induced by oxidative stress and reversed the reduced-RUNX3 expression by H2O2 treatment (Fig. 1E).
Therefore, to determine whether HDAC1 and G9a are important for the oxidative stress-induced mislocalization of RUNX3 from the nucleus to the cytoplasm, siRNAs targeting HDAC1 and G9a were used. Treatment with siHDAC1 RNA or siG9a RNA restored the nuclear localization of RUNX3, which was reduced by oxidative stress (Fig. 1F and G).
HDAC1 and G9a Activate Src Following Oxidative Stress
Our earlier study revealed that oxidative stress stimulates RUNX3 phosphorylation at tyrosine residues through Src activation, leading to mislocalization [13]. HDAC1 and G9a knockdown attenuated oxidative stress-induced Src and RUNX3 phosphorylation at tyrosine residues (Fig. 2A and B). These results suggested that oxidative stress-induced HDAC1 and G9a induced Src activation and led to RUNX3 phosphorylation, resulting in the cytoplasmic RUNX3 localization.
Oxidative Stress Induces JAB1 and CRM1 Interaction Via HDAC1 Or G9a-Induced Src Activation
JAB1 induces the cytoplasmic localization and degradation of RUNX3 [10, 11]. JAB1-mediated nuclear export requires CRM1, a member of the importin-related nuclear transport receptor family [24, 25]. Thus, we examined whether JAB1 is involved in oxidative stress-induced cytoplasmic RUNX3 localization. JAB1 and CRM1 expression increased in H2O2-treated cells; however, this effect was attenuated by NAC treatment (Fig. 3A). The interaction between JAB1 and CRM1 also increased in H2O2-treated cells, as determined by immunoprecipitation and PLA (Fig. 3B and C). Moreover, knockdown of HDAC1, G9a, and Src attenuated oxidative stress-induced JAB1 expression (Fig. 3D and E).
Oxidative Stress Induces RUNX3 Mislocalization Via RUNX3, JAB1, and CRM1 Interaction
To determine whether the JAB1-mediated RUNX3 nuclear export is CRM1-dependent, we investigated the interactions of RUNX3 with JAB1 and CRM1. PLA and immunoprecipitation revealed that JAB1 and CRM1 interacted with RUNX3 in H2O2-treated cells (Fig. 4A-C). To investigate the JAB1-mediated degradation of RUNX3 induced by oxidative stress, we used the proteasome inhibitor, carbobenzoxyl-L-leucyl-L-leucyl-L-leucine (MG132). H2O2 treatment downregulated RUNX3 via JAB1 induction, however, RUNX3 downregulation was inhibited by MG132 (Fig. 4D). These data implied that JAB1 promoted RUNX3 degradation via the proteasome activity. In addition, JAB1 knockdown or treatment with a CRM1 inhibitor, leptomycin B, markedly increased the nuclear localization of RUNX3 in H2O2-treated cells (Fig. 4E and F). These data suggested that JAB1-mediated RUNX3 nuclear export required a CRM1-dependent pathway.
Discussion
Oxidative imbalances that generate excessive ROS may play a direct or indirect role in the initiation, promotion, and development of carcinogenesis [26]. DNA and chromosomes are damaged by ROS, which can interact with oncogenes or tumor suppressor genes, induce epigenetic changes in DNA or histones, and alter immunological mechanisms [27, 28]. RUNX3 regulates cell proliferation, apoptosis, and differentiation. In various cancer cell types, RUNX3 is inactivated due to epigenetic silencing and cytoplasmic localization from the nucleus to the cytoplasm, thereby losing its function as a tumor suppressor [8]. Previously, we documented that oxidative stress promoteed RUNX3 mislocalization via HDAC1-induced Src activation and RUNX3 expression inhibition via DNA methylation in colon cancer cells [13, 19].
This study addressed the impact of oxidative stress on the unusual localization of RUNX3 in colon cancer cells and examined the role of histone modification-related proteins and nuclear exporters in this process. The results showed that under oxidative stress, the nuclear RUNX3 localization decreased and accumulated in the cytoplasm. We also found that the expression of the histone modifiers, HDAC1 and G9a, was induced by oxidative stress. In addition, the use of siRNAs to inhibit HDAC1 and G9a resulted in a reversal of the cytoplasmic localization of RUNX3, which was promoted by oxidative stress, suggesting that RUNX3 mislocalization was linked to histone deacetylation and methylation processes. As previously stated, oxidative stress promotes HDAC1 upregulation in colon cancer cells [13, 20]. HDAC1 and G9a overexpression inhibits the nuclear localization and RUNX3 expression under hypoxic condition in gastric cancer cells [18]. Under certain condition, hypoxia contributes to the formation of ROS [29]. Moreover, H. pylori infection promotes the mislocalization of p27 and decreases p27 expression by inhibiting histone acetylation within the p27 promoter [30].
Suberoylanilide hydroxamic acid, an HDAC inhibitor, effectively reduces the pro-oncogenic effect of the hepatitis B virus pre-S2 mutant oncoprotein in hepatocellular carcinoma cells and promotes the generation of the tumor suppressor protein thioredoxin-binding protein 2 (TBP2), which consequently strengthens the association between JAB1 and TBP2, and suppresses the degradation of p27 triggered by pre-S2 mutants [31, 32].
Src activation-mediated RUNX3 phosphorylation in H. pylori-infected intestines leads to the cytoplasmic localization of RUNX3 and causes intestinal metastasis [15]. In addition, H. pylori-induced ROS production in gastric epithelial cells can affect cellular signal transduction, leading to gastric carcinogenesis [33]. Our results showed that oxidative stress induces Src activation, which in turn phosphorylates the tyrosine residues of RUNX3 and induces cytosolic RUNX3 localization.
JAB1 is an essential component of the COP9 signalosome and is a multifunctional protein involved in integrin signaling, cell cycle regulation, and development [34, 35]. JAB1 is associated with the initiation and progression of numerous types of cancer, including hepatocellular carcinoma [35, 36]. The Mpr1/Pad1 N-terminal domain of JAB1 and the runt domain of RUNX3 physically interact; which enhances CRM1-dependent nuclear transportation of RUNX3 by JAB1. Furthermore, the sequestered cytosolic RUNX3 is subsequently eliminated by a process that depends upon the proteasome [10, 11]. Our data showed that JAB1 was activated by oxidative stress and that treatment with siHDAC1 RNA, siG9a RNA, and siSrc RNA inhibited JAB1 expression. JAB1 enhances the nuclear export of the tumor suppression proteins p27 and p53 by serving as a molecular mediator of CRM1, a carrier protein for nuclear export, and induces subsequent cytoplasmic degradation of these proteins [11, 37]. JAB1 and CRM1 interactions were induced and the cytoplasmic localization of RUNX3 was increased by oxidative stress. Treatment with siHDAC1 RNA, siG9a RNA, and siSrc RNA inhibited JAB1 expression, suggesting that the functional inhibition of RUNX3 during oxidative stress occurred, in part, via JAB1 and CRM1 mediated-mislocalization by HDAC1 or G9a-induced Src activation. Our findings demonstrated that the cytoplasmic distribution of RUNX3 in colon cancer cells under oxidative stress can be targeted for the development of novel therapy, as well as serving as potential biomarkers for the prediction of the occurrence of colon cancer.
Data Availability
All data and materials in the manuscript will be made available to the corresponding authors.
References
Lotem, J., et al. (2017). Runx3 in immunity, inflammation and cancer. Advances in Experimental Medicine and Biology, 962, 369–393.
Ito, Y., Bae, S. C., & Chuang, L. S. (2015). The RUNX family: Developmental regulators in cancer. Nature Reviews Cancer, 15(2), 81–95.
Toska, A., Modi, N., & Chen, L. F. (2023). RUNX3 meets the ubiquitin-proteasome system in cancer. Cells, 12(5), 717.
Tsang, Y. H., Lamb, A., & Chen, L. F. (2011). New insights into the inactivation of gastric tumor suppressor RUNX3: the role of H. pylori infection. Journal of Cellular Biochemistry, 112(2), 381–386.
Zhou, X., et al. (2017). Mislocalization of Runt-related transcription factor 3 results in airway inflammation and airway hyper-responsiveness in a murine asthma model. Experimental and Therapeutic Medicine, 14(3), 2695–2701.
Zhou, W. N., et al. (2019). Inactivation of RUNX3 protein expression in tongue squamous cell carcinoma and its association with clinicopathological characteristics. Molecular Medicine Reports, 19(2), 885–894.
Chen, X., et al. (2018). Loss of expression rather than cytoplasmic mislocalization of RUNX3 predicts worse outcome in non-small cell lung cancer. Oncology Letters, 15(4), 5043–5055.
Chuang, L. S. H., et al. (2023). Matsuo J, Douchi D, Bte Mawan NA, Ito Y. RUNX3 in stem cell and cancer biology. Cells, 12(3), 408.
Krishnan, V. (2023). The RUNX family of proteins, DNA repair, and cancer. Cells, 12(8), 1106.
Kim, J. H., et al. (2009). Jab1/CSN5 induces the cytoplasmic localization and degradation of RUNX3. Journal of Cellular Biochemistry, 107, 557–565.
Kugimiya, N., et al. (2017). JAB1-STAT3 activation loop is associated with recurrence following 5-fluorouracil-based adjuvant chemotherapy in human colorectal cancer. Oncology Letters, 14(5), 6203–6209.
Shackleford, T. J., et al. (2011). Stat3 and CCAAT/enhancer binding protein beta (C/EBP-beta) regulate Jab1/CSN5 expression in mammary carcinoma cells. Breast Cancer Research, 13, R65.
Kang, K. A., et al. (2017). Cytoplasmic localization of RUNX3 via histone deacetylase-mediated src expression in oxidative-stressed colon cancer cells. Journal of Cellular Physiology, 232(7), 1914–1921.
Goh, Y. M., et al. (2010). Src kinase phosphorylates RUNX3 at tyrosine residues and localizes the protein in the cytoplasm. Journal of Biological Chemistry, 285, 10122–10129.
Cinghu, S., et al. (2012). Phosphorylation of the gastric tumor suppressor RUNX3 following H. pylori infection results in its localization to the cytoplasm. Journal of Cellular Physiology, 227, 1071–1080.
Kundaktepe, B. P., et al. (2021). The evaluation of oxidative stress parameters in breast and colon cancer. Medicine, 100(11), e25104.
Jelic, M. D., et al. (2021). Oxidative stress and its role in cancer. Journal of Cancer Research and Therapeutics, 17(1), 22–28.
Lee, S. H., et al. (2009). Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells. Oncogene, 28, 184–194.
Kang, K. A., et al. (2013). Oxidative stress induces proliferation of colorectal cancer cells by inhibiting RUNX3 and activating the Akt signaling pathway. International Journal of Oncology, 43, 1511–1516.
Kang, K. A., et al. (2012). Epigenetic changes induced by oxidative stress in colorectal cancer cells: Methylation of tumor suppressor RUNX3. Tumour Biology, 33, 403–412.
Chang, C. J., et al. (2008). PTEN nuclear localization is regulated by oxidative stress and mediates p53-dependent tumor suppression. Molecular and Cellular Biology, 28(10), 3281–3289.
García-Yagüe, Á. J., et al. (2013). Nuclear import and export signals control the subcellular localization of Nurr1 protein in response to oxidative stress. Journal of Biological Chemistry, 288(8), 5506–5517.
Gajewska, K. A., et al. (2021). Nuclear transporter Importin-13 plays a key role in the oxidative stress transcriptional response. Nature Communications, 12(1), 5904.
Wang, D., et al. (2011). The role of p27(Kip1) phosphorylation at serine 10 in the migration of malignant glioma cells in vitro. Neoplasma, 58(1), 65–73.
Yang, Y., et al. (2023). Regulatory mechanisms and therapeutic potential of JAB1 in neurological development and disorders. Molecular Medicine, 29(1), 80.
Cheung, E. C., & Vousden, K. H. (2022). The role of ROS in tumour development and progression. Nature Reviews Cancer, 22(5), 280–297.
Wei, J., et al. (2019). Radiation-induced normal tissue damage: Oxidative stress and epigenetic mechanisms. Oxidative Medicine and Cellular Longevity, 2019, 3010342.
Zheng, X., & Sawalha, A. H. (2022). The role of oxidative stress in epigenetic changes underlying autoimmunity. Antioxidants & Redox Signaling, 36(7–9), 423–440.
Yu, L. M., et al. (2019). Hypoxia-induced ROS contribute to myoblast pyroptosis during obstructive sleep apnea via the NF-κB/HIF-1α signaling pathway. Oxidative Medicine and Cellular Longevity, 2019, 4596368.
Wen, S., et al. (2012). Promotion of cytoplasmic mislocalization of p27 by Helicobacter pylori in gastric cancer. Oncogene, 31(14), 1771–1780.
Fu, X., et al. (2016). Ubiquitin-like proteasome system represents a eukaryotic-like pathway for targeted proteolysis in archaea. Microbiology,7(3), e00379-16.
Hsieh, Y. H., et al. (2013). Histone deacetylase inhibitor suberoylanilide hydroxamic acid suppresses the pro-oncogenic effects induced by hepatitis B virus pre-S2 mutant oncoprotein and represents a potential chemopreventive agent in high-risk chronic HBV patients. Carcinogenesis, 34(2), 475–485.
Li, B., et al. (2023). Helicobacter pylori infection induces autophagy via ILK regulation of NOXs-ROS-Nrf2/HO-1-ROS loop. World Journal of Microbiology and Biotechnology, 39(10), 284.
Yao, W., et al. (2022). Activation of esterase D by FPD5 inhibits growth of A549 lung cancer cells via JAB1/p53 pathway. Genes, 13(5), 786.
Guo, Z., et al. (2019). The pivotal oncogenic role of Jab1/CSN5 and its therapeutic implications in human cancer. Gene, 687, 219–227.
Yuan, C., et al. (2021). Jab1/Cops5: A promising target for cancer diagnosis and therapy. International Journal of Clinical Oncology, 26(7), 1159–1169.
Lee, W. S., et al. (2012). Expression of p53, p27 and Jab1 protein in epithelial ovarian tumors. European Journal of Gynaecological Oncology, 33(4), 358–362.
Funding
J.W.H. received research support from the National Research Foundation of Korea (NRF), funded by the Ministry of Education (RS-2023–00270936), Ministry of Science and the ICT (NRF-2023R1A2C1002770).
Author information
Authors and Affiliations
Contributions
J.W.H. and K.A.K. contributed to study conception and design. Experimentation, data collection, and analysis were performed by K.A.K. and M.J.P. Flow cytometry analysis and microscopic imaging were performed by K.A.K., P.D.S.M.F., and H.M.U.L.H. The first draft of the manuscript was written by J.W.H. and K.A.K., and the manuscript was revised and edited by H.J.B. and S.P.Y. All authors have read and approved the final version of the manuscript.
Corresponding author
Ethics declarations
Ethical Approval
Not applicable.
Consent to Participate
Not applicable.
Consent to Publication
Not applicable.
Conflict of Interest
The authors declare no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Kang, K.A., Piao, M.J., Fernando, P.D.S.M. et al. Oxidative Stress-Mediated RUNX3 Mislocalization Occurs Via Jun Activation Domain-Binding Protein 1 and Histone Modification. Appl Biochem Biotechnol (2024). https://doi.org/10.1007/s12010-024-04944-0
Accepted:
Published:
DOI: https://doi.org/10.1007/s12010-024-04944-0